Buy One Get One free -Llimited Time Offer X
Ikgdar 500 Injection is a prescription drug, available for use as Injection. Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia are some of its major therapeutic uses. Ikgdar 500 Injection also has some secondary and off-label uses. These are listed below.
The optimal dosage of Ikgdar 500 Injection is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
The side effects typically associated with Ikgdar 500 Injection include Weakness. Some other side effects of Ikgdar 500 Injection have been listed ahead. These side effects of Ikgdar 500 Injection are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Ikgdar 500 Injection's effect during pregnancy is Moderate and Severe while nursing. Warnings related to Ikgdar 500 Injection's effects on the liver, heart and kidney, if any, have been listed below.
Ikgdar 500 Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. Hyperkalemia are examples of such conditions. Other conditions have been mentioned below in the Ikgdar 500 Injection contraindications section.
Drug reaction of Ikgdar 500 Injection with other medicines has been reported. See below for a complete list.
You should also be aware that Ikgdar 500 Injection is not safe while driving, and is not addiction.
Ikgdar 500 Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Ikgdar 500 Injection is used -
Moderate
Mild
Common
Is the use of Ikgdar 500 Injection safe for pregnant women?
Ikgdar can have harmful effects in pregnant women. If you experience any discomfort after using Ikgdar, then discontinue the use and take your doctor's advice.
Is the use of Ikgdar 500 Injection safe during breastfeeding?
Ikgdar may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Ikgdar 500 Injection on the Kidneys?
There can be some harmful effects on your kidneys after taking Ikgdar. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Ikgdar 500 Injection on the Liver?
Ikgdar is not harmful for the liver.
What is the effect of Ikgdar 500 Injection on the Heart?
There may be an adverse effect on the heart after taking Ikgdar. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
If you are suffering from any of the following diseases, you should not take Ikgdar 500 Injection unless your doctor advises you to do so -
Is this Ikgdar 500 Injection habit forming or addictive?
No, you will not get addicted to Ikgdar 500 Injection.
Is it safe to drive or operate heavy machinery when consuming?
After taking Ikgdar 500 Injection, you should not drive or work on any heavy machine, as Ikgdar 500 Injection can make you drowsy.
Is it safe?
Ikgdar 500 Injection should be used only after doctor's advice.
Is it able to treat mental disorders?
Ikgdar 500 Injection is unable to treat or cure mental disorders.
Interaction between Food and Ikgdar 500 Injection
Taking Ikgdar 500 Injection with food is safe.
Interaction between Alcohol and Ikgdar 500 Injection
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Ikgdar 500 Injection.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rituxan (rituximab)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1106-1109
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872